Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 304,962 | 167,058 | 36,973 | 34,468 | 38,165 |
| Marketable Securities | 0 | 34,651 | 99,050 | 165,731 | 173,418 |
| Receivables | 12,388 | N/A | N/A | N/A | N/A |
| Inventories | 16,136 | N/A | N/A | N/A | N/A |
| Other current assets | 11,566 | 3,924 | 1,334 | 1,653 | 1,434 |
| TOTAL | $345,896 | $211,714 | $142,632 | $203,924 | $213,577 |
| Non-Current Assets | |||||
| PPE Net | 1,276 | 1,145 | 520 | 435 | 674 |
| Investments And Advances | 0 | 0 | 243 | 73,420 | 30,906 |
| Intangibles | 56 | 56 | 56 | 56 | 56 |
| Other Non-Current Assets | 6,030 | 1,532 | 0 | 0 | 0 |
| TOTAL | $7,362 | $2,733 | $819 | $73,911 | $31,636 |
| Total Assets | $353,258 | $214,447 | $143,451 | $277,835 | $245,213 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 1,045 | 1,709 |
| Accounts payable and accrued liabilities | 51,975 | 28,856 | 44,893 | 20,375 | 4,595 |
| Accrued Expenses | 7,663 | 17,511 | 16,039 | 10,506 | 8,138 |
| Other current liabilities | 5,392 | 5,236 | N/A | N/A | N/A |
| TOTAL | $94,069 | $66,080 | $64,333 | $33,144 | $15,589 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 1,022 |
| Deferred Revenues | 1,662 | 2,152 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 355,323 | 128,417 | 0 | 0 | 0 |
| TOTAL | $355,323 | $128,417 | $N/A | $N/A | $1,022 |
| Total Liabilities | $449,392 | $194,497 | $64,333 | $33,144 | $16,611 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27,943 | 27,512 | 26,825 | 26,499 | 22,555 |
| Common Shares | 26 | 27 | 27 | 26 | 23 |
| Retained earnings | -838,817 | -695,266 | -598,101 | -396,291 | -229,200 |
| Other shareholders' equity | 2 | 23 | -319 | -845 | -172 |
| TOTAL | $-96,134 | $19,950 | $79,118 | $244,691 | $228,602 |
| Total Liabilities And Equity | $353,258 | $214,447 | $143,451 | $277,835 | $245,213 |